Furthermore, DUSP6/MKP-3 is one of a small group of genes that is consistently upregulated in response to elevated ERK signalling in cancer cells harbouring activating mutations in either Ras or Braf, where it is presumed to restrain oncogenic ERK signalling [19], [20], [21]. The gene discussed is BRAF; the disease is cancer.